CEACAM5 and metastatic colorectal cancer: TCR-T cell therapies targeting carcinoembryonic antigen in metastatic colorectal cancers have mediated tumour regression but induce severe transient colitis, probably because of the normal expression of CEA in healthy colonic mucosa [9].